Showing results (731-740 of 784) with videos related to
Sort By:
Pageof 79
Gene|June 16, 2010
Complete sequence and gene organization of the mitochondrial genome for Hubbard's sportive lemur (Lepilemur hubbardorum)Runhua Lei, Gary D Shore, Rick A Brenneman, et al.Biomedicine|November 16, 2022
Preliminary Study of Structural Changes of Glucose-6-Phosphate Dehydrogenase Deficiency VariantsNaveen E Louis, Muaawia A Hamza, Puteri Nsd Engku Baharuddin Baharuddin, et al.BMC Biology|December 25, 2007
Extensive population genetic structure in the giraffeDavid M Brown, Rick A Brenneman, Klaus-Peter Koepfli, et al.Journal of Crohn'S & Colitis|December 22, 2010
Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitisN Eleftheriadis, G Lambrecht, G D'Haens, et al.Optics Letters|March 19, 2008
Spectral-purity-enhancing layer for multilayer mirrorsM M J W van Herpen, R W E van de Kruijs, D J W Klunder, et al.Primates; Journal of Primatology|June 9, 2016
Primate genotyping via high resolution melt analysis: rapid and reliable identification of color vision status in wild lemursRachel L Jacobs, Amanda N Spriggs, Tammie S MacFie, et al.The American Journal of Gastroenterology|August 13, 1999
Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research GroupJ Belaiche, E Louis, G D'Haens, et al.Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.Acta Gastro-Enterologica Belgica|March 22, 2018
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumabH Peeters, E Louis, F Baert, et al.Pageof 79